Grifols, S.A. Total Shareholders Equity 2011-2026 | GRFS

Annual Total Shareholders Equity Grifols, S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	6.72 B	6.85 B	4.7 B	3.63 B	3.73 B	3.3 B	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
6.85 B	3.3 B	4.82 B

Quarterly Total Shareholders Equity Grifols, S.A.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	7.32 B	-	-	-	6.72 B	-	-	-	6.85 B	-	-	-	4.7 B	-	-	-	3.63 B	-	-	-	3.73 B	-	-	-	3.3 B	-	-	-	2.66 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
7.32 B	2.66 B	4.86 B

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Athira Pharma ATHA	27.8 M	-	-	$ 269 M	USA
BioNTech SE BNTX	1.37 B	$ 94.83	-0.7 %	$ 27.2 B	Germany
Checkmate Pharmaceuticals CMPI	69.5 M	-	-	$ 231 M	USA
INmune Bio INMB	23.5 M	$ 1.54	0.01 %	$ 38.1 M	USA
ACADIA Pharmaceuticals ACAD	733 M	$ 22.48	0.58 %	$ 3.73 B	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	-302 M	$ 3.13	0.55 %	$ 651 M	USA
Can-Fite BioPharma Ltd. CANF	5.59 M	$ 3.46	-1.14 %	$ 5.7 M	Israel
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Exelixis EXEL	2.16 B	$ 48.55	9.3 %	$ 13.2 B	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	-27.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	176 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	169 M	-	-	$ 28.6 M	USA
AlloVir ALVR	78.8 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	189 M	$ 24.03	2.6 %	$ 3.06 B	USA
Allena Pharmaceuticals ALNA	18.9 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	3.36 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	179 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	16.9 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	-17.1 M	-	-	$ 8.42 M	USA
Aravive ARAV	10.7 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	-24.2 M	-	17.91 %	$ 11.1 M	USA
CRISPR Therapeutics AG CRSP	1.92 B	$ 54.84	4.7 %	$ 4.93 B	Schweiz
Avenue Therapeutics ATXI	1.83 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	178 M	$ 1.73	5.18 %	$ 460 M	Britain
Fortress Biotech FBIO	49.9 M	$ 2.57	4.27 %	$ 71.7 M	USA
AVROBIO AVRO	94.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
Atreca BCEL	78.4 M	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	-9.98 M	-	-2.5 %	$ 5.88 M	USA